In last trading session, GeneDx Holdings Corp (NASDAQ:WGS) saw 0.73 million shares changing hands with its beta currently measuring 2.08. Company’s recent per share price level of $89.38 trading at -$7.19 or -7.45% at ring of the bell on the day assigns it a market valuation of $2.46B. That closing price of WGS’s stock is at a discount of -10.62% from its 52-week high price of $98.87 and is indicating a premium of 96.81% from its 52-week low price of $2.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.65 million shares which gives us an average trading volume of 633.49K if we extend that period to 3-months.
For GeneDx Holdings Corp (WGS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.11 in the current quarter.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Upright in the red during last session for losing -7.45%, in the last five days WGS remained trading in the green while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $89.38 price level, adding 9.6% to its value on the day. GeneDx Holdings Corp’s shares saw a change of 16.29% in year-to-date performance and have moved 12.24% in past 5-day. GeneDx Holdings Corp (NASDAQ:WGS) showed a performance of 22.67% in past 30-days. Number of shares sold short was 2.15 million shares which calculate 4.09 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 45 to the stock, which implies a fall of -98.62% to its current value. Analysts have been projecting 34 as a low price target for the stock while placing it at a high target of 70. It follows that stock’s current price would jump 61.96% in reaching the projected high whereas dropping to the targeted low would mean a gain of 61.96% for stock’s current value.
GeneDx Holdings Corp (WGS) estimates and forecasts
Statistics highlight that GeneDx Holdings Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 161.19% of value to its shares in past 6 months, showing an annual growth rate of 95.38% while that of industry is 5.10. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 42.27% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 80.22M for the same. And 6 analysts are in estimates of company making revenue of 77.8M in the next quarter. Company posted 57.42M and 62.42M of sales in current and next quarters respectively a year earlier.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
Insiders are in possession of 18.19% of company’s total shares while institution are holding 73.01 percent of that, with stock having share float percentage of 89.24%. Investors also watch the number of corporate investors in a company very closely, which is 73.01% institutions for GeneDx Holdings Corp that are currently holding shares of the company. CASDIN CAPITAL, LLC is the top institutional holder at WGS for having 3.53 million shares of worth $92.18 million. And as of 2024-06-30, it was holding 13.2482 of the company’s outstanding shares.
The second largest institutional holder is CORVEX MANAGEMENT LP, which was holding about 2.47 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2937 of outstanding shares, having a total worth of $64.66 million.
On the other hand, Alger Small Cap Focus Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 461.76 shares of worth $41.27 million or 1.68% of the total outstanding shares. The later fund manager was in possession of 410.78 shares on Sep 30, 2024 , making its stake of worth around $36.72 million in the company or a holder of 1.50% of company’s stock.
